Jason M. Bottiglieri
Keine laufenden Positionen mehr
Profil
Jason M.
Bottiglieri served as President, Chief Executive Officer & Director at Infraredx, Inc. He was also Chief Executive Officer & Director at InnovHeart Srl from 2018 to 2020.
Prior to that, he worked as Manager-New England Region at Johnson & Johnson and Manager-New England Division at Cordis Cardiology.
He also served as Manager-Eastern Region at Medtronic Corp.
from 2008 to 2011.
Bottiglieri completed his undergraduate degree from Florida Atlantic University.
Ehemalige bekannte Positionen von Jason M. Bottiglieri
Unternehmen | Position | Ende |
---|---|---|
InnovHeart Srl
InnovHeart Srl Medical SpecialtiesHealth Technology InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy. | Vorstandsvorsitzender | 06.08.2020 |
Medtronic Corp. | Corporate Officer/Principal | - |
JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Cordis Cardiology
Cordis Cardiology Miscellaneous Commercial ServicesCommercial Services Part of Cardinal Health, Inc., Cordis Cardiology engages in development and manufacturing of interventional cardiovascular and endovascular technologies. The company is based in Miami Lakes, FL. The CEO of the company is Shar Matin. | Corporate Officer/Principal | - |
Infraredx, Inc.
Infraredx, Inc. Medical SpecialtiesHealth Technology Infraredx, Inc. is a developed cardiovascular imaging devices. Its product were TVC Imaging System dual-modality intravascular imaging system with the ability to assess vessel structure and plaque composition via integrated NIRS near infrared spectroscopy lipid-core plaque LCP detection and enhanced IVUS imaging technology. The company was founded by James E. Muller in 1999 and was headquartered in Bedford, MA. | Vorstandsvorsitzender | - |
Ausbildung von Jason M. Bottiglieri
Florida Atlantic University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
JOHNSON & JOHNSON | Health Technology |
Private Unternehmen | 4 |
---|---|
Infraredx, Inc.
Infraredx, Inc. Medical SpecialtiesHealth Technology Infraredx, Inc. is a developed cardiovascular imaging devices. Its product were TVC Imaging System dual-modality intravascular imaging system with the ability to assess vessel structure and plaque composition via integrated NIRS near infrared spectroscopy lipid-core plaque LCP detection and enhanced IVUS imaging technology. The company was founded by James E. Muller in 1999 and was headquartered in Bedford, MA. | Health Technology |
Medtronic Corp. | |
Cordis Cardiology
Cordis Cardiology Miscellaneous Commercial ServicesCommercial Services Part of Cardinal Health, Inc., Cordis Cardiology engages in development and manufacturing of interventional cardiovascular and endovascular technologies. The company is based in Miami Lakes, FL. The CEO of the company is Shar Matin. | Commercial Services |
InnovHeart Srl
InnovHeart Srl Medical SpecialtiesHealth Technology InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy. | Health Technology |